AI
OMIC

Acuitas Investments’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Acuitas Investments’s Portfolio OMIC Stock Details OMIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-17,396
Closed -$199K – 129
2023
Q3 		$199K Sell
17,396
-4,667
-21% -$86.7K 0.12% 106
2023
Q2 		$549K Buy
+22,063
New +$646K 0.32% 83

Other funds holding OMIC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
QM
QVIDTVM Management The Woodlands, Texas $81.4M AUM 2.94% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acuitas Investments's OMIC Position: Q4 2023 in Review

Acuitas Investments sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q4 2023, closing a stake of 17,396 shares — an estimated $199K sold.

Acuitas Investments first reported a position in OMIC in Q2 2023 and held it in 2 quarters. The position peaked at $549K in Q2 2023. 47 funds tracked by Wall St. Rank hold OMIC as of Q4 2023.

  • Acuitas Investments reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Acuitas Investments sold 17,396 Singular Genomics Systems, Inc. Common Stock shares in Q4 2023, an estimated $199K.
  • Acuitas Investments first reported a position in Singular Genomics Systems, Inc. Common Stock in Q2 2023 and held it in 2 quarters.
  • Acuitas Investments's Singular Genomics Systems, Inc. Common Stock position peaked at $549K in Q2 2023.
  • 47 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q4 2023.

Based on Acuitas Investments's 13F filing for Q4 2023, filed 2 Feb 2024.